Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment response

2020 ◽  
Vol 273 ◽  
pp. 131-137
Author(s):  
Ole Köhler-Forsberg ◽  
Louisa G. Sylvia ◽  
Valerie L. Ruberto ◽  
Maya Kuperberg ◽  
Alec P. Shannon ◽  
...  
2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Yael Haberman ◽  
Rebekah Karns ◽  
Phillip J. Dexheimer ◽  
Melanie Schirmer ◽  
Judith Somekh ◽  
...  

2011 ◽  
Vol 26 (2) ◽  
pp. 96-106 ◽  
Author(s):  
Robert M. Post ◽  
Gabriele S. Leverich ◽  
Lori L. Altshuler ◽  
Mark A. Frye ◽  
Trisha Suppes ◽  
...  

2003 ◽  
Vol 48 (7) ◽  
pp. 449-457 ◽  
Author(s):  
Christopher Baethge ◽  
Leonardo Tondo ◽  
Irene M Bratti ◽  
Tom Bschor ◽  
Michael Bauer ◽  
...  

Objective: To analyze new and reviewed findings to evaluate relations between treatment response and latency from onset of bipolar disorder (BD) to the start of mood-stabilizer prophylaxis. Method: We analyzed our own new data and added findings from research reports identified by computerized searching. Results: We found 11 relevant studies, involving 1485 adult patients diagnosed primarily with BD. Reported latency to prophylaxis averaged 9.6 years (SD 1.3), and follow-up in treatment averaged 5.4 years (SD 3.1). Greater illness intensity and shorter treatment latency were closely associated, resulting in a greater apparent reduction in morbidity with earlier treatment. However, this finding was not sustained after correction for pretreatment morbidity, and treatment latency did not predict morbidity during treatment. Therefore, assessments based on improvement with treatment, or without correction for pretreatment morbidity, can be misleading. Conclusions: Available evidence does not support the proposal that delayed prophylaxis may limit response to prophylactic treatment in BD and related disorders.


2018 ◽  
Vol 1 (6) ◽  
pp. e183779 ◽  
Author(s):  
Hayley C. Warsinske ◽  
Aditya M. Rao ◽  
Flora M. F. Moreira ◽  
Paulo Cesar P. Santos ◽  
Andrew B. Liu ◽  
...  

2018 ◽  
Author(s):  
Azmeraw T. Amare ◽  
Klaus Oliver Schubert ◽  
Liping Hou ◽  
Scott R. Clark ◽  
Sergi Papiol ◽  
...  

AbstractBackgroundLithium is a first-line medication for bipolar disorder (BD), but only ~30% of patients respond optimally to the drug. Since genetic factors are known to mediate lithium treatment response, we hypothesized whether polygenic susceptibility to the spectrum of depression traits is associated with treatment outcomes in patients with BD. In addition, we explored the potential molecular underpinnings of this relationship.MethodsWeighted polygenic scores (PGSs) were computed for major depressive disorder (MDD) and depressive symptoms (DS) in BD patients from the Consortium on Lithium Genetics (ConLi+Gen; n=2,586) who received lithium treatment. Lithium treatment outcome was assessed using the ALDA scale. Summary statistics from genome-wide association studies (GWAS) in MDD (130,664 cases and 330,470 controls) and DS (n=161,460) were used for PGS weighting. Associations between PGSs of depression traits and lithium treatment response were assessed by binary logistic regression. We also performed a cross-trait meta-GWAS, followed by Ingenuity® Pathway Analysis.OutcomesBD patients with a low polygenic load for depressive traits were more likely to respond well to lithium, compared to patients with high polygenic load (MDD: OR =1.64 [95%CI: 1.26-2.15], lowest vs highest PGS quartiles; DS: OR=1.53 [95%CI: 1.18-2.00]). Associations were significant for type 1, but not type 2 BD. Cross-trait GWAS and functional characterization implicated voltage-gated potassium channels, insulin-related pathways, mitogen-activated protein-kinase (MAPK) signaling, and miRNA expression.InterpretationGenetic loading to depression traits in BD patients lower their odds of responding optimally to lithium. Our findings support the emerging concept of a lithium-responsive biotype in BD.FundingSee attached details


Author(s):  
HR Keir ◽  
A Shoemark ◽  
ML Crichton ◽  
A Dicker ◽  
J Pollock ◽  
...  

2005 ◽  
Vol 3 (3) ◽  
pp. 103-110
Author(s):  
Edith M. Jolin ◽  
Elizabeth B. Weller ◽  
Ronald A. Weller

2017 ◽  
Vol 19 (7) ◽  
pp. 552-562 ◽  
Author(s):  
Satoshi Saito ◽  
Kumiko Fujii ◽  
Yuji Ozeki ◽  
Kenichi Ohmori ◽  
Gyo Honda ◽  
...  

2018 ◽  
Vol 238 ◽  
pp. 383-391 ◽  
Author(s):  
Kristen K. Ellard ◽  
Aishwarya G. Gosai ◽  
Emily E. Bernstein ◽  
Navneet Kaur ◽  
Lousia G. Sylvia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document